Brief: Novan Focuses Strategic Direction, Announces Restructuring

NVN Liquidation

31/05/2023 22:02

May 31 (Reuters) - Novan Inc  NOVN.O :
    * NOVAN FOCUSES STRATEGIC DIRECTION AND ANNOUNCES
RESTRUCTURING
    * NOVAN INC - DIRECTING RESOURCES ON POTENTIAL APPROVAL OF
BERDAZIMER GEL, 10.3% (SB206) FOR MOLLUSCUM CONTAGIOSUM
    * NOVAN INC - PROCESS TO EXPLORE A SALE OR OUT-LICENSE OF
COMMERCIAL ASSETS OR OTHER BUSINESS TRANSACTION CONTINUES
    * NOVAN INC - CONTINUED PROGRESS TOWARD PDUFA GOAL DATE OF
JANUARY
5, 2024, FOR BERDAZIMER GEL, 10.3%
    * NOVAN INC - CONTINUED PROGRESS TOWARD PDUFA GOAL DATE OF
JANUARY
5, 2024, FOR BERDAZIMER GEL, 10.3%
    * NOVAN INC - WILL IMMEDIATELY REDUCE CERTAIN OF ITS
OPERATING
EXPENSES CURRENTLY SUPPORTING ITS COMMERCIAL OPERATIONS.
    * NOVAN - TO SELL AND DISTRIBUTE COMMERCIAL PRODUCTS, INCUR
CERTAIN RELATED EXPENSES ASSOCIATED WITH RHOFADE, WYNZORA,
MINOLIRA, CLODERM IN U.S.
    * NOVAN - EXISTING CASH AND CASH EQUIVALENTS AS OF MARCH 31
TO
PROVIDE CO WITH LIQUIDITY TO FUND PLANNED OPERATIONS INTO LATE
JUNE

Source text for Eikon:  ID:nGNX4T8hRr 
Further company coverage:  NOVN.O 

 ((Reuters.Briefs@thomsonreuters.com;))